Pulmonary Arterial Hypertension (PAH) Therapeutics Market to Reach USD 13.5 Bn by 2028, rising at a CAGR of 5.4% - Global Analysis by TMR
May 08, 2023 08:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, May 08, 2023 (GLOBE NEWSWIRE) -- The pulmonary arterial hypertension (PAH) therapeutics market was valued at USD 5.2 Bn in 2020, and is projected to reach USD...
Pulmonary Arterial Hypertension Market Worth ($10.88 Billion by 2028) Lead by Asia Pacific Region (6.5% CAGR) – Global Report by The Insight Partners
February 28, 2023 09:03 ET
|
The Insight Partners
New York, Feb. 28, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Pulmonary Arterial Hypertension Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and...
Pulmonary Arterial Hypertension Market to Garner USD 12 Billion by 2031, Claims Allied Market Research
November 15, 2022 19:00 ET
|
Allied Market Research
Portland, OR, Nov. 15, 2022 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global pulmonary arterial hypertension market generated $7.2 billion in 2021, and is...